The latest generation of defibrillators can perform a variety of tasts, including detect deterioration in various heart functions and tell a patient how to adjust medications.In the New York Times, yesterday, Gina Kolata explored these devices, their challenges, and their implications for the future of medicine.

June 22, 2010

1 Min Read
New York Times Features Smart Heart Implants

As she says, defibrillators including the Consulta from Boston Scientific, the Cognis from Medtronic, and the Epic from St. Jude Medical  "are part of a new wave of smart implantable devices that is transforming the care of people with heart disease and creating a bonanza for researchers." The devices have transmitters that send data over 20–30 ft, meaning that key data capture, such as weight and blood pressure can happen at the bedside, communicated over the phone.

These devices, which are being tested in clinical trials, have the potential to save lives, reduce medical expenses, and provide guidance for heart patients toward managing their symptoms.

Sign up for the QMED & MD+DI Daily newsletter.

You May Also Like